Title	Publication Date	Language	Citations
Burden of Migraine in Europe Using Self-Reported Digital Diary Data from the Migraine Buddy© Application	2018/10/06	English	40
The Humanistic and Economic Burden of Alzheimer's Disease	2022/02/22	English	40
Natalizumab Discontinuation and Treatment Strategies in Patients with Multiple Sclerosis (MS): A Retrospective Study from Two Italian MS Centers	2015/12/01	English	39
Emerging Immunotherapies for Parkinson Disease	2018/12/11	English	39
Design and Rationale of the Global Phase 3 NEURO-TTRansform Study of Antisense Oligonucleotide AKCEA-TTR-LRx (ION-682884-CS3) in Hereditary Transthyretin-Mediated Amyloid Polyneuropathy	2021/02/26	English	37
Emerging Infection, Vaccination, and Guillain–Barré Syndrome: A Review	2021/06/12	English	35
Risk of Adverse Outcomes for Older People with Dementia Prescribed Antipsychotic Medication: A Population Based e-Cohort Study	2017/01/04	English	35
Consensus Management of Gastrointestinal Events Associated with Delayed-Release Dimethyl Fumarate: A Delphi Study	2015/11/02	English	33
Neuroprotective Effect of Trans-Resveratrol in Mild to Moderate Alzheimer Disease: A Randomized, Double-Blind Trial	2021/08/16	English	32
Burden of Migraine in Japan: Results of the ObserVational Survey of the Epidemiology, tReatment, and Care Of MigrainE (OVERCOME [Japan]) Study	2021/12/03	English	32
Reflections on the Utility of the Retina as a Biomarker for Alzheimer’s Disease: A Literature Review	2019/12/01	English	32
A Review on MS-Based Blood Biomarkers for Alzheimer’s Disease	2019/12/01	English	32
The Study of Postmortem Human Synaptosomes for Understanding Alzheimer’s Disease and Other Neurological Disorders: A Review	2017/07/01	English	30
A Review of the Social, Psychological, and Economic Burdens Experienced by People with Spina Bifida and Their Caregivers	2013/03/22	English	30
Post-COVID-19 Syndrome is Rarely Associated with Damage of the Nervous System: Findings from a Prospective Observational Cohort Study in 171 Patients	2022/08/26	English	30
Sustained Effect of Delayed-Release Dimethyl Fumarate in Newly Diagnosed Patients with Relapsing–Remitting Multiple Sclerosis: 6-Year Interim Results From an Extension of the DEFINE and CONFIRM Studies	2016/03/01	English	30
A Review of Biomarkers for Neurodegenerative Disease: Will They Swing Us Across the Valley?	2017/07/01	English	30
A Videogame-Based Digital Therapeutic to Improve Processing Speed in People with Multiple Sclerosis: A Feasibility Study	2018/11/30	English	29
5HT6 Antagonists in the Treatment of Alzheimer’s Dementia: Current Progress	2018/05/02	English	29
Only Follow-Up of Memory B Cells Helps Monitor Rituximab Administration to Patients with Neuromyelitis Optica Spectrum Disorders	2018/06/07	English	29
Chronic Treatment with the 5-HT1A Receptor Partial Agonist Tandospirone Increases Hippocampal Neurogenesis	2014/01/03	English	29
Migraine and Ischemic Stroke: A Mendelian Randomization Study	2021/12/13	English	28
Phase 1 Parkinson’s Disease Studies Show the Dopamine D1/D5 Agonist PF-06649751 is Safe and Well Tolerated	2018/10/25	English	28
A Systematic Review and Mixed Treatment Comparison of Pharmaceutical Interventions for Multiple Sclerosis	2020/09/28	English	27
Current Directions in Deep Brain Stimulation for Parkinson’s Disease—Directing Current to Maximize Clinical Benefit	2020/03/09	English	27
The Lived Experience of Myasthenia Gravis: A Patient-Led Analysis	2021/10/23	English	27
Priority of Treatment Outcomes for Caregivers and Patients with Mild Cognitive Impairment: Preliminary Analyses	2016/08/09	English	27
High-Risk PML Patients Switching from Natalizumab to Alemtuzumab: an Observational Study	2016/12/03	English	26
Therapeutic Effects of Batoclimab in Chinese Patients with Generalized Myasthenia Gravis: A Double-Blinded, Randomized, Placebo-Controlled Phase II Study	2022/04/12	English	26
A Clinical-Radiomics Nomogram for Functional Outcome Predictions in Ischemic Stroke	2021/06/25	English	26